Eira Poikonen
Current Organizations / Institutes
The organizations/institutes from the scholar's latest article
Research Subjects
Eira Poikonen has a total of 14 co-authors. Here are the top co-authors by number of shared publications:
Outi Lyytikäinen
2 shared publicationsPetri Ruutu
2 shared publications- Hannu Syrjälä
Department of Infection Control, Oulu University Hospital, Oulu, Finland
1 shared publication - Irma Koivula
Department of Medicine, Kuopio University Hospital, Kuopio, Finland
1 shared publication - Jukka Lumio
Department of Internal Medicine, Tampere University Hospital, Tampere, Finland
1 shared publication - Jukka Ollgren
Division of Health Security, Finnish Institute for Health and Welfare, Helsinki, Finland
1 shared publication
Latest Publications
- Open Access
- 28 October 2010
- Published by Springer Nature in BMC Infectious Diseases
- Vol. 10 (1) , 312
Secular trend in candidemia and the use of fluconazole in Finland, 2004-2007
In a previous study we observed an increasing trend in candidemia in Finland in the 1990s. Our aim was now to investigate further population-based secular trends, as well as outcome, and evaluate the association of fluconazole consumption and prophylaxis policy with the observed findings.
- 28 October 2010
- Published by Springer Nature in BMC Infectious Diseases
- Vol. 10 (1) , 312
Open AccessSecular trend in candidemia and the use of fluconazole in Finland, 2004-2007
In a previous study we observed an increasing trend in candidemia in Finland in the 1990s. Our aim was now to investigate further population-based secular trends, as well as outcome, and evaluate the association of fluconazole consumption and prophylaxis policy with the observed findings.
- 1 January 2009
- Published by Taylor & Francis in Scandinavian Journal of Infectious Diseases
- Vol. 41 (8) , 590-596
Nosocomial candidaemia in a Finnish tertiary care centre during 1987–2004
We studied the epidemiology of nosocomial candidaemia by assessing the incidence and outcome of illness and causative species in a large Finnish tertiary care centre during 1987-2004. A total of 364 episodes were observed; annual incidence varied between 0.26 per 10,000 patient-d in 2000 and 0.59 in 1989. The most common species were C. albicans (65%), C. parapsilosis (13%), and C. glabrata (9%). The proportion of C. albicans decreased from 71% during 1987-1992 to 58% during 1999-2004, and C. glabrata increased from 3% to 14%, respectively. The proportion of intensive care patients increased from 27% during 1987-1992 to 44% by 1999-2004, associated with neonates and surgical patients. The 1-month case fatality ranged from 30% to 33%. Nosocomial candidaemias did not increase, but the distribution of Candida spp. changed. Mortality remained high. The observed changes may reflect differences in prevention strategies that need to be explored for further improvements in prevention.
- 1 January 2009
- Published by Taylor & Francis in Scandinavian Journal of Infectious Diseases
- Vol. 41 (8) , 590-596
Nosocomial candidaemia in a Finnish tertiary care centre during 1987–2004
We studied the epidemiology of nosocomial candidaemia by assessing the incidence and outcome of illness and causative species in a large Finnish tertiary care centre during 1987-2004. A total of 364 episodes were observed; annual incidence varied between 0.26 per 10,000 patient-d in 2000 and 0.59 in 1989. The most common species were C. albicans (65%), C. parapsilosis (13%), and C. glabrata (9%). The proportion of C. albicans decreased from 71% during 1987-1992 to 58% during 1999-2004, and C. glabrata increased from 3% to 14%, respectively. The proportion of intensive care patients increased from 27% during 1987-1992 to 44% by 1999-2004, associated with neonates and surgical patients. The 1-month case fatality ranged from 30% to 33%. Nosocomial candidaemias did not increase, but the distribution of Candida spp. changed. Mortality remained high. The observed changes may reflect differences in prevention strategies that need to be explored for further improvements in prevention.
- Open Access
- 1 August 2003
- Published by Centers for Disease Control and Prevention (CDC) in Emerging Infectious Diseases
- Vol. 9 (8) , 985-990
Candidemia in Finland, 1995–1999
We analyzed laboratory-based surveillance candidemia data from the National Infectious Disease Register in Finland and reviewed cases of candidemia from one tertiary-care hospital from 1995 to 1999. A total of 479 candidemia cases were reported to the Register. The annual incidence rose from 1.7 per 100,000 population in 1995 to 2.2 in 1999. Species other than Candida albicans accounted for 30% of cases without change in the proportion. A total of 79 cases of candidemia were identified at the hospital; the rate varied from 0.03 to 0.05 per 1,000 patient-days by year. Predisposing factors included indwelling catheters (81%), gastrointestinal surgery (27%), hematologic malignancy (25%), other types of surgery (21%), and solid malignancies (20%). Crude 7-day and 30-day case-fatality ratios were 15% and 35%, respectively. The rate of candidemia increased in Finland but is still substantially lower than in the United States. No shift to non–C. albicans species could be detected.
- 1 August 2003
- Published by Centers for Disease Control and Prevention (CDC) in Emerging Infectious Diseases
- Vol. 9 (8) , 985-990
Open AccessCandidemia in Finland, 1995–1999
We analyzed laboratory-based surveillance candidemia data from the National Infectious Disease Register in Finland and reviewed cases of candidemia from one tertiary-care hospital from 1995 to 1999. A total of 479 candidemia cases were reported to the Register. The annual incidence rose from 1.7 per 100,000 population in 1995 to 2.2 in 1999. Species other than Candida albicans accounted for 30% of cases without change in the proportion. A total of 79 cases of candidemia were identified at the hospital; the rate varied from 0.03 to 0.05 per 1,000 patient-days by year. Predisposing factors included indwelling catheters (81%), gastrointestinal surgery (27%), hematologic malignancy (25%), other types of surgery (21%), and solid malignancies (20%). Crude 7-day and 30-day case-fatality ratios were 15% and 35%, respectively. The rate of candidemia increased in Finland but is still substantially lower than in the United States. No shift to non–C. albicans species could be detected.